Piper Jaffray initiates coverage on Boston Scientific (NYSE: BSX) with a Buy rating and a $16 price target.
...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE